559 related articles for article (PubMed ID: 27339668)
21. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
[TBL] [Abstract][Full Text] [Related]
22. Systematic Review of the Evolution of Health-Economic Evaluation Models of Osteoarthritis.
Zhao T; Ahmad H; de Graaff B; Xia Q; Winzenberg T; Aitken D; Palmer AJ
Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1617-1627. PubMed ID: 32799431
[TBL] [Abstract][Full Text] [Related]
23. A Systematic Review of the Economic and Humanistic Burden of Gout.
Shields GE; Beard SM
Pharmacoeconomics; 2015 Oct; 33(10):1029-47. PubMed ID: 25969152
[TBL] [Abstract][Full Text] [Related]
24. The economic burden of bronchiectasis - known and unknown: a systematic review.
Goeminne PC; Hernandez F; Diel R; Filonenko A; Hughes R; Juelich F; Solomon GM; Upton A; Wichmann K; Xu W; Chalmers JD
BMC Pulm Med; 2019 Feb; 19(1):54. PubMed ID: 30819166
[TBL] [Abstract][Full Text] [Related]
25. Cost-of-illness studies of diabetes mellitus: a systematic review.
Ng CS; Lee JY; Toh MP; Ko Y
Diabetes Res Clin Pract; 2014 Aug; 105(2):151-63. PubMed ID: 24814877
[TBL] [Abstract][Full Text] [Related]
26. Cost-of-illness studies of inherited retinal diseases: a systematic review.
Ng QX; Ong C; Yaow CYL; Chan HW; Thumboo J; Wang Y; Koh GCH
Orphanet J Rare Dis; 2024 Feb; 19(1):93. PubMed ID: 38424595
[TBL] [Abstract][Full Text] [Related]
27. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition.
Gupta S; Hawker GA; Laporte A; Croxford R; Coyte PC
Rheumatology (Oxford); 2005 Dec; 44(12):1531-7. PubMed ID: 16091394
[TBL] [Abstract][Full Text] [Related]
28. A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.
Ruchlin HS; Insinga RP
Pharmacoeconomics; 2008; 26(11):925-35. PubMed ID: 18850762
[TBL] [Abstract][Full Text] [Related]
29. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
30. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding.
Liu Z; Doan QV; Blumenthal P; Dubois RW
Value Health; 2007; 10(3):183-94. PubMed ID: 17532811
[TBL] [Abstract][Full Text] [Related]
31. The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.
Diamantopoulos A; Wright E; Vlahopoulou K; Cornic L; Schoof N; Maher TM
Pharmacoeconomics; 2018 Jul; 36(7):779-807. PubMed ID: 29492843
[TBL] [Abstract][Full Text] [Related]
32. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States.
White AG; Birnbaum HG; Janagap C; Buteau S; Schein J
J Occup Environ Med; 2008 Sep; 50(9):998-1005. PubMed ID: 18784547
[TBL] [Abstract][Full Text] [Related]
33. Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review.
McDonald M; Patel DA; Keith MS; Snedecor SJ
Ocul Surf; 2016 Apr; 14(2):144-67. PubMed ID: 26733111
[TBL] [Abstract][Full Text] [Related]
34. Addressing obesity in the management of knee and hip osteoarthritis - weighing in from an economic perspective.
Flego A; Dowsey MM; Choong PF; Moodie M
BMC Musculoskelet Disord; 2016 May; 17():233. PubMed ID: 27229924
[TBL] [Abstract][Full Text] [Related]
35. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013.
Soliman AM; Yang H; Du EX; Kelkar SS; Winkel C
Am J Obstet Gynecol; 2015 Aug; 213(2):141-60. PubMed ID: 25771213
[TBL] [Abstract][Full Text] [Related]
36. Economic burden of knee and hip osteoarthritis in Spain.
Loza E; Lopez-Gomez JM; Abasolo L; Maese J; Carmona L; Batlle-Gualda E;
Arthritis Rheum; 2009 Feb; 61(2):158-65. PubMed ID: 19177521
[TBL] [Abstract][Full Text] [Related]
37. Cost-of-illness studies in systemic lupus erythematosus: A systematic review.
Zhu TY; Tam LS; Li EK
Arthritis Care Res (Hoboken); 2011 May; 63(5):751-60. PubMed ID: 21557530
[TBL] [Abstract][Full Text] [Related]
38. Disease burden on health care by pain severity and usual analgesic treatment in patients with symptomatic osteoarthritis: a Spanish nationwide health survey.
Rejas-Gutierrez J; Llopart-Carles N; García-López S; Darbà J
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):711-719. PubMed ID: 32772591
[TBL] [Abstract][Full Text] [Related]
39. Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension.
Gu S; Hu H; Dong H
Pharmacoeconomics; 2016 Jun; 34(6):533-50. PubMed ID: 26714685
[TBL] [Abstract][Full Text] [Related]
40. Direct and indirect costs of osteoarthritis in Singapore: a comparative study among multiethnic Asian patients with osteoarthritis.
Xie F; Thumboo J; Fong KY; Lo NN; Yeo SJ; Yang KY; Li SC
J Rheumatol; 2007 Jan; 34(1):165-71. PubMed ID: 17216684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
